All listings for this product
Save on Textbooks
- AU $69.88Trending at AU $71.29
- AU $32.44Trending at AU $38.14
- AU $45.07Trending at AU $52.06
- AU $33.00Trending at AU $35.68
- AU $21.88Trending at AU $34.44
- AU $30.12Trending at AU $32.49
- AU $20.37Trending at AU $22.08
About this product
- DescriptionThe blood cell system has provided a model system that has been used by many researchers to investigate how a stem cell can give rise to a wide variety of mature cell types. The principles that emerged in developmental biology have been applied to the structure of tissues throughout the body. However, many of the principles have been challenged by recent findings, changing the way we view blood cell development. In turn, this has impacted our understanding of the origin and nature of leukaemia, as well as cancer in general. Like the development of any body tissue, cancer is an organised and hierarchical tissue with its own identity. A new viewpoint is that the mutations that give rise to cancer re-programme cancer cells to their own abrmal pattern of tissue development. Understanding how the hierarchy of tumour identity differs from that of rmal tissue provides important new avenues to the development of new treatments for cancer. No doubt further refinement to our understanding of rmal and cancer cells will continue for many years to come. Even so, we appear to be moving towards an exciting prospect of providing the key to unlocking the long standing mystery of primary cellular events that undermine and distort our rmal cells and give rise to the disease of cancer. The importance of this is the prospect of developing new treatments for cancer. In particular, the distorted behaviour of cancer cells might be reversible so that they can be restored to their rmal state. Diversity, Versatility and Leukaemia examines how rmal and cancer cells are inextricably linked, and focuses on the changes to how we view the development of rmal cells and the subversion of this process in cancer.
- Author BiographyGeoffrey Brown is Reader in Cellular Immunology at the College of Medical and Dental Sciences at the University of Birmingham, UK and Director of the EU-funded Marie Curie FP7 Initial Training Network and consortium DECIDE (Decision-making within cells and differentiation entity therapies). He received a BSc in microbiology from Queen Elizabeth College, University of London and a PhD in tumour biology from University College, London. Postdoctoral research was at the MRC Immunochemistry Unit, Oxford and the Nuffield Department of Clinical Medicine, Oxford. At Oxford, Geoffrey was also the IBM Fellow, University of Oxford and Research Lecturer of the House, Christ Church College. His early work described human B and T lymphocyte antigens leading to the discovery of the common acute lymphoblastic leukaemia antigen (CD10). This led to designation of the childhood leukaemia as common acute lymphoblastic leukaemia (cALL). His research for many years has concerned the development of blood cells and Geoffrey has proposed the pair-wise model for blood cell development.
- Author(s)Geoffrey Brown,Isidro Sanchez-Garcia
- PublisherNova Science Publishers Inc
- Date of Publication01/04/2016
- SubjectClinical Medicine: Professional
- Place of PublicationNew York
- Country of PublicationUnited States
- ImprintNova Science Publishers Inc
- Weight320 g
- Width155 mm
- Height230 mm
This item doesn't belong on this page.
Thanks, we'll look into this.